Hematopoietic stem cell transplantation in children

Julie A. Kolins; Cara Zbylut; Susan McCollom; Victor M. Aquino

doi:10.1016/j.ccell.2011.02.004

Hematopoietic stem cell transplantation in children

Julie A. Kolins, Cara Zbylut, Susan McCollom, Victor M. Aquino

Research output: Contribution to journal › Review article › peer-review

4 Scopus citations

Abstract

Medical and nursing care of the hematopoietic stem cell transplantation (HSCT) recipient are complex because of the pathophysiology, HSCT process, pre-HSCT conditioning regimens, numerous medications and therapies, acute and chronic complications, adverse effects, resources involved, and environmental considerations. The HSCT process and therapies may affect any body system, requiring proficient and prioritized nursing care, possibly in an intensive care setting. Understanding the timing of potential adverse effects and complications based on engraftment will help provide competent, high-acuity care. Although autogenic and allogeneic HSCT are curative treatment options, there are numerous morbidity and/or mortality risks throughout the HSCT journey.

Original language	English (US)
Pages (from-to)	349-376
Number of pages	28
Journal	Critical Care Nursing Clinics of North America
Volume	23
Issue number	2
DOIs	https://doi.org/10.1016/j.ccell.2011.02.004
State	Published - Jun 2011

Keywords

Bone marrow
HLA typing
Hematopoietic stem cell transplant
Leukemia
Nursing care
Pediatric

ASJC Scopus subject areas

Critical Care

Access to Document

10.1016/j.ccell.2011.02.004

Cite this

@article{a1117dbf59c44545a4d313b36a2a1cb1,

title = "Hematopoietic stem cell transplantation in children",

abstract = "Medical and nursing care of the hematopoietic stem cell transplantation (HSCT) recipient are complex because of the pathophysiology, HSCT process, pre-HSCT conditioning regimens, numerous medications and therapies, acute and chronic complications, adverse effects, resources involved, and environmental considerations. The HSCT process and therapies may affect any body system, requiring proficient and prioritized nursing care, possibly in an intensive care setting. Understanding the timing of potential adverse effects and complications based on engraftment will help provide competent, high-acuity care. Although autogenic and allogeneic HSCT are curative treatment options, there are numerous morbidity and/or mortality risks throughout the HSCT journey.",

keywords = "Bone marrow, HLA typing, Hematopoietic stem cell transplant, Leukemia, Nursing care, Pediatric",

author = "Kolins, {Julie A.} and Cara Zbylut and Susan McCollom and Aquino, {Victor M.}",

year = "2011",

month = jun,

doi = "10.1016/j.ccell.2011.02.004",

language = "English (US)",

volume = "23",

pages = "349--376",

journal = "Critical Care Nursing Clinics of North America",

issn = "0899-5885",

publisher = "W.B. Saunders Ltd",

number = "2",

}

TY - JOUR

T1 - Hematopoietic stem cell transplantation in children

AU - Kolins, Julie A.

AU - Zbylut, Cara

AU - McCollom, Susan

AU - Aquino, Victor M.

PY - 2011/6

Y1 - 2011/6

N2 - Medical and nursing care of the hematopoietic stem cell transplantation (HSCT) recipient are complex because of the pathophysiology, HSCT process, pre-HSCT conditioning regimens, numerous medications and therapies, acute and chronic complications, adverse effects, resources involved, and environmental considerations. The HSCT process and therapies may affect any body system, requiring proficient and prioritized nursing care, possibly in an intensive care setting. Understanding the timing of potential adverse effects and complications based on engraftment will help provide competent, high-acuity care. Although autogenic and allogeneic HSCT are curative treatment options, there are numerous morbidity and/or mortality risks throughout the HSCT journey.

AB - Medical and nursing care of the hematopoietic stem cell transplantation (HSCT) recipient are complex because of the pathophysiology, HSCT process, pre-HSCT conditioning regimens, numerous medications and therapies, acute and chronic complications, adverse effects, resources involved, and environmental considerations. The HSCT process and therapies may affect any body system, requiring proficient and prioritized nursing care, possibly in an intensive care setting. Understanding the timing of potential adverse effects and complications based on engraftment will help provide competent, high-acuity care. Although autogenic and allogeneic HSCT are curative treatment options, there are numerous morbidity and/or mortality risks throughout the HSCT journey.

KW - Bone marrow

KW - HLA typing

KW - Hematopoietic stem cell transplant

KW - Leukemia

KW - Nursing care

KW - Pediatric

UR - http://www.scopus.com/inward/record.url?scp=79957597620&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79957597620&partnerID=8YFLogxK

U2 - 10.1016/j.ccell.2011.02.004

DO - 10.1016/j.ccell.2011.02.004

M3 - Review article

C2 - 21624696

AN - SCOPUS:79957597620

SN - 0899-5885

VL - 23

SP - 349

EP - 376

JO - Critical Care Nursing Clinics of North America

JF - Critical Care Nursing Clinics of North America

IS - 2

ER -

Hematopoietic stem cell transplantation in children

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this